NO180451C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 13-alkyl-11<beta>-fenylgonaner - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 13-alkyl-11<beta>-fenylgonaner

Info

Publication number
NO180451C
NO180451C NO905609A NO905609A NO180451C NO 180451 C NO180451 C NO 180451C NO 905609 A NO905609 A NO 905609A NO 905609 A NO905609 A NO 905609A NO 180451 C NO180451 C NO 180451C
Authority
NO
Norway
Prior art keywords
radicals
alkyl
preparation
therapeutically active
analogous process
Prior art date
Application number
NO905609A
Other languages
English (en)
Norwegian (no)
Other versions
NO905609D0 (no
NO180451B (no
NO905609L (no
Inventor
Stefan Scholz
Eckhard Ottow
Guenter Neef
Walter Elger
Sybille Beier
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO905609D0 publication Critical patent/NO905609D0/no
Publication of NO905609L publication Critical patent/NO905609L/no
Priority to NO960829A priority Critical patent/NO960829D0/no
Publication of NO180451B publication Critical patent/NO180451B/no
Publication of NO180451C publication Critical patent/NO180451C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
NO905609A 1988-07-01 1990-12-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive 13-alkyl-11<beta>-fenylgonaner NO180451C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO960829A NO960829D0 (no) 1988-07-01 1996-02-29 Fremgangsmåte for fresmtilling av 13-alkyl-11 r

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3822770A DE3822770A1 (de) 1988-07-01 1988-07-01 13-alkyl-11ss-phenylgonane
PCT/DE1989/000443 WO1990000174A1 (fr) 1988-07-01 1989-07-03 13-ALKYL-11β-PHENYLGONANES

Publications (4)

Publication Number Publication Date
NO905609D0 NO905609D0 (no) 1990-12-27
NO905609L NO905609L (no) 1991-02-28
NO180451B NO180451B (no) 1997-01-13
NO180451C true NO180451C (no) 1997-04-23

Family

ID=6358021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905609A NO180451C (no) 1988-07-01 1990-12-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive 13-alkyl-11<beta>-fenylgonaner

Country Status (17)

Country Link
US (2) US5273971A (fr)
EP (1) EP0349481B1 (fr)
JP (1) JP2956776B2 (fr)
AT (1) ATE129717T1 (fr)
AU (1) AU644060B2 (fr)
CA (1) CA1334668C (fr)
DD (2) DD287511A5 (fr)
DE (2) DE3822770A1 (fr)
ES (1) ES2080079T3 (fr)
GR (1) GR3018069T3 (fr)
HU (1) HU208021B (fr)
IE (1) IE70664B1 (fr)
IL (1) IL90826A (fr)
NO (1) NO180451C (fr)
PT (1) PT91031B (fr)
WO (1) WO1990000174A1 (fr)
ZA (1) ZA895058B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
US5707982A (en) * 1989-02-24 1998-01-13 Roussel Uclaf 19-nor-steroids
US6790971B1 (en) * 1989-02-24 2004-09-14 Aventis Pharma S.A. 19-Nor-steroids
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
DE4042004A1 (de) * 1990-12-22 1992-06-25 Schering Ag 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
EP0683172B1 (fr) * 1994-05-19 1997-08-13 Akzo Nobel N.V. Dérivés 11,21-bisphényle-19-nor-pregnanes
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
CA2253673C (fr) * 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derives de progesterone substitues 21 pouvant etre utilises comme nouveaux agents antiprogestatifs
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK882003A3 (en) * 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
EP1613640A4 (fr) * 2003-02-28 2010-05-19 Us Gov Health & Human Serv Procede de preparation de 17 alpha-acetoxy-11 beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, d'intermediaires de ceux-ci et procedes de preparation desdits intermediaires
TW200531977A (en) * 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
US20060196449A1 (en) * 2004-09-17 2006-09-07 Mockry Eldon F Fluid heating system and method
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (fr) * 2006-09-26 2008-04-03 The Regents Of The University Of California Méthodes et compositions pour la prévention et le traitement du cancer
EP3693376A1 (fr) 2006-10-24 2020-08-12 Allergan Pharmaceuticals International Limited Compositions pour supprimer la prolifération endométriale
US7784843B2 (en) * 2008-01-08 2010-08-31 Toyota Motor Engineering & Manufacturing North America, Inc. Vehicle console with sliding panel
US8172293B2 (en) * 2008-01-09 2012-05-08 Toyota Motor Engineering & Manufacturing North America, Inc. Vehicle electronic device support systems
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
EP2550288A1 (fr) 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions et procédés pour l'apport non toxique d'antiprogestines
CN105142644A (zh) 2013-03-12 2015-12-09 阿尔诺治疗公司 奥那司酮多晶型形式和使用方法
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
US10786461B2 (en) 2014-11-17 2020-09-29 Context Biopharma Inc. Onapristone extended-release compositions and methods
BR112018005999A2 (pt) 2015-09-25 2019-01-08 Context Biopharma Inc métodos para a produção de intermediários de onapristona
KR20180113988A (ko) 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971772A (en) * 1975-01-06 1976-07-27 E. R. Squibb & Sons, Inc. Steroidal[16α,17-b]1,4-dioxanes and Steroidal[16α,17-b]1,4-dioxins
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide

Also Published As

Publication number Publication date
IL90826A0 (en) 1990-01-18
JP2956776B2 (ja) 1999-10-04
ATE129717T1 (de) 1995-11-15
NO905609D0 (no) 1990-12-27
EP0349481A1 (fr) 1990-01-03
NO180451B (no) 1997-01-13
DD295638A5 (de) 1991-11-07
IE892141L (en) 1990-01-01
DD287511A5 (de) 1991-02-28
US5446036A (en) 1995-08-29
CA1334668C (fr) 1995-03-07
WO1990000174A1 (fr) 1990-01-11
AU644060B2 (en) 1993-12-02
JPH03505727A (ja) 1991-12-12
DE3822770A1 (de) 1990-01-04
PT91031B (pt) 1994-12-30
EP0349481B1 (fr) 1995-11-02
HUT56114A (en) 1991-07-29
NO905609L (no) 1991-02-28
IL90826A (en) 1994-06-24
HU208021B (en) 1993-07-28
DE58909476D1 (de) 1995-12-14
US5273971A (en) 1993-12-28
ZA895058B (en) 1990-04-25
ES2080079T3 (es) 1996-02-01
AU3856889A (en) 1990-01-23
PT91031A (pt) 1990-02-08
HU894130D0 (en) 1991-06-28
GR3018069T3 (en) 1996-02-29
IE70664B1 (en) 1996-12-11

Similar Documents

Publication Publication Date Title
NO180451C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 13-alkyl-11&lt;beta&gt;-fenylgonaner
FI943838A0 (fi) Vinyleeniatsaindolijohdannaiset ja menetelmä niiden valmistamiseksi
FI845066L (fi) 11 -arylestradiener, deras framstaellning och dessa innehaollande farmaceutiska produkter.
FI924569A (fi) Foerfarande foer enantioselektiv framstaellning av fenylisoserinderivat
JPS51143673A (en) New derivatives of 4-aminopiperidines
FI73969B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva trans-4-aminometylcyklohexankarboxylsyraderivat.
FI873064A (fi) Stabiliserade oxazafosforinloesningar och foerfarande foer framstaellning av dessa.
ES8403877A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
DK288686A (da) Farmaceutiske praeparater
ATE169921T1 (de) Optisch aktive beta-aminoalkoxyborankomplexe
DK0630428T3 (da) Fremgangsmåde til fremstilling af taxanderivater
IL92280A0 (en) Oxime ether derivatives,their preparation and fungicidal compositions containing them
ES8502700A1 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.
FI892229A0 (fi) Antibiotikafoereningar.
ES484246A1 (es) Procedimiento de preparacion de nuevos derivados de ortoclo-robenzoil-2-cloro-4 glicilanilidas
JPS5285167A (en) Novel oxazoline derivatives
JPS53108981A (en) Thioisocarbostyril derivative and its preparation